Patents
Literature
5 results about "Tryptamine" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Tryptamine is a monoamine alkaloid. It contains an indole ring structure, and is structurally similar to the amino acid tryptophan, from which the name derives. Tryptamine is found in trace amounts in the brains of mammals and is hypothesized to play a role as a neuromodulator or neurotransmitter. Similar to other trace amines, tryptamine binds to human trace amine-associated receptor 1 (TAAR1) as an agonist.
Seabuckthorn seed meal extract containing tryptamine alkaloids, uses and detection methods thereof
The present application provides an extract based on seabuckthorn seed meal and having the effects of improving sleep and memory. The present application also provides the use and detection method of the extract.
Owner:NORTHWEST INST OF PLATEAU BIOLOGY CHINESE ACAD OF SCI
Triptamine prodrugs as serotonin receptor activators for the treatment of, for example, depression
Owner:REUNION NEUROSCIENCE INC MORRISTOWN
Deamidoed ergot tetralines for the treatment of brain disorders
Provided herein are tetracyclic heterocyclic compounds useful in methods of treating a disease or for increasing neural plasticity. These compounds can also be used to increase dendritic spine density.
Owner:RGT UNIV OF CALIFORNIA +1
Compositions and uses of psilocybin and psilocin
The present disclosure provides a method of treating or ameliorating a disease or disorder comprising administering to a subject a crystalline form of a composition comprising crystalline forms A, B, and C of psilocin and psilocybin. The disclosure further provides a method of stimulating neurogenesis or neurite growth resulting in an increase in neuronal length.
Owner:ZYLORION HEALTH INC
5-Methoxy-N,N-dimethyltryptamine for use in the treatment of psychiatric disorders in nursing mothers
5-Methoxy-N,N-dimethyltryptamine (5-MeO-DMT) or a pharmaceutically acceptable salt thereof for use in the treatment of a psychiatric or nervous system disorder in mothers of children aged 18 months or less.
Owner:GH RES IRELAND LTD